Funder: [National Institutes of Health - https://www.nih.gov]

Due Dates: January 5, 2027 (Next due date) | Recurring standard SBIR/STTR due dates apply

Funding Amounts: Phase I: Typically 6-12 months; Phase II: Typically 2 years; budgets vary by IC, with possible waivers for larger awards. Fee up to 7% allowed.

Summary: Supports small businesses in developing improved clinical diagnostics that address health disparities caused by current assays or devices lacking diverse patient representation.

Key Information: Clinical trials are not allowed under this FOA; foreign involvement must be justified and disclosed; applicants must be U.S.-based small businesses.